(Q44447910)

3 December 2017

title

Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis (English)

1 reference

amyotrophic lateral sclerosis

3 December 2017

main subject

0 references

kynurenic acid

1 reference

ChEBI release 2020-05-28

2

Kocki T

1 reference

3 December 2017

4

Turski WA

1 reference

3 December 2017

Iłzecka J

1

1 reference

3 December 2017

Stelmasiak Z

series ordinal

3

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Acta Neurologica Scandinavica

3 December 2017

published in

1 reference

3 December 2017

volume

107

1 reference

3 December 2017

issue

6

1 reference

3 December 2017

page(s)

412-418

1 reference

Mechanism and treatment of motoneuron degeneration in ALS: what have SOD1 mutants told us?

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

21 January 2018

Excitotoxicity in ALS.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Differential expression of Group I metabotropic glutamate receptors in motoneurons at low and high risk for degeneration in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

GluR2 AMPA receptor subunit expression in motoneurons at low and high risk for degeneration in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Differential cortico-motoneuron vulnerability after chronic mitochondrial inhibition in vitro and the role of glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Identification and quantification of kynurenic acid in human brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Comparative behavioral and pharmacological studies with centrally administered kynurenine and kynurenic acid in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Excitatory amino acid antagonists protect mice against seizures induced by bicuculline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Kynurenine metabolism in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Kynurenine pathway abnormalities in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Cloning and functional expression of a soluble form of kynurenine/alpha-aminoadipate aminotransferase from rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Characterization of rat brain kynurenine aminotransferases I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Brain concentrations of kynurenic acid after a systemic neuroprotective dose in the gerbil model of global ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Excitatory aminoacid antagonists provide a therapeutic approach to neurological disorders.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Neuroprotective potency of kynurenic acid against excitotoxicity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Systemic kainic acid administration in rats: effects on kynurenic acid production in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Kynurenate inhibition of cell excitation decreases stroke size and deficits

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Presymptomatic motor neuron loss and reactive astrocytosis in the SOD1 mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Increase in kynurenic acid in Huntington's disease motor cortex

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Formation of endogenous glutamatergic receptors antagonist kynurenic acid--differences between cortical and spinal cord slices

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Some metabotropic glutamate receptor ligands reduce kynurenate synthesis in rats by intracellular inhibition of kynurenine aminotransferase II

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Increased cerebrospinal fluid quinolinic acid, kynurenic acid, and L-kynurenine in acute septicemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Serotonin metabolism in migraine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Nutritional management in amyotrophic lateral sclerosis: a worldwide perspective

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Effects of vitamin B6 deficiency on the conversion ratio of tryptophan to niacin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00076.X

7 January 2021

10.1034/J.1600-0404.2003.00076.X

Identifiers

DOI

1 reference

3 December 2017

1 reference